http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 16 Jul 2026 07:17:49 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Investing/Why+Psychedelic+stocks+are+surging+today/26776644.html <p>Investing.com -- Shares of psychedelic drug developers are surging premarket on Thursday after Eli Lilly announced a definitive agreement to acquire AtaiBeckley Inc., validating the sector and lifting sentiment across the space. </p> <p dir="ltr"></p> <p dir="ltr">AtaiBeckley shares are up 30.8% premarket, while Compass Pathways is up 7.4% and GH Research is up 18.9%.</p> <p dir="ltr">Under the deal, Lilly will acquire all outstanding AtaiBeckley shares for $6.75 per share in cash, plus up to $2.50 per share through a Contingent Value Right tied to development and regulatory milestones for AtaiBeckley&amp;#39;s lead programs, BPL-003 and VLS-01. </p> <p dir="ltr">The upfront cash consideration represents an aggregate equity value of http://www.streetinsider.com/Investing/Why+Psychedelic+stocks+are+surging+today/26776644.html Thu, 16 Jul 2026 07:17:49 -0400 ATAI GHRS http://www.streetinsider.com/Investing/Why+Psychedelic+stocks+are+surging+today/26776644.html <p>Investing.com -- Shares of psychedelic drug developers are surging premarket on Thursday after Eli Lilly announced a definitive agreement to acquire AtaiBeckley Inc., validating the sector and lifting sentiment across the space. </p> <p dir="ltr"></p> <p dir="ltr">AtaiBeckley shares are up 30.8% premarket, while Compass Pathways is up 7.4% and GH Research is up 18.9%.</p> <p dir="ltr">Under the deal, Lilly will acquire all outstanding AtaiBeckley shares for $6.75 per share in cash, plus up to $2.50 per share through a Contingent Value Right tied to development and regulatory milestones for AtaiBeckley&amp;#39;s lead programs, BPL-003 and VLS-01. </p> <p dir="ltr">The upfront cash consideration represents an aggregate equity value of http://www.streetinsider.com/Investing/Why+Psychedelic+stocks+are+surging+today/26776644.html Thu, 16 Jul 2026 07:17:49 -0400 ATAI GHRS http://www.streetinsider.com/General+News/Why+Psychedelic+stocks+are+surging+today/26776644.html <p>Investing.com -- Shares of psychedelic drug developers are surging premarket on Thursday after Eli Lilly announced a definitive agreement to acquire AtaiBeckley Inc., validating the sector and lifting sentiment across the space. </p> <p dir="ltr"></p> <p dir="ltr">AtaiBeckley shares are up 30.8% premarket, while Compass Pathways is up 7.4% and GH Research is up 18.9%.</p> <p dir="ltr">Under the deal, Lilly will acquire all outstanding AtaiBeckley shares for $6.75 per share in cash, plus up to $2.50 per share through a Contingent Value Right tied to development and regulatory milestones for AtaiBeckley&amp;#39;s lead programs, BPL-003 and VLS-01. </p> <p dir="ltr">The upfront cash consideration represents an aggregate equity value of http://www.streetinsider.com/General+News/Why+Psychedelic+stocks+are+surging+today/26776644.html Thu, 16 Jul 2026 07:17:49 -0400 ATAI GHRS http://www.streetinsider.com/General+News/Why+Psychedelic+stocks+are+surging+today/26776644.html <p>Investing.com -- Shares of psychedelic drug developers are surging premarket on Thursday after Eli Lilly announced a definitive agreement to acquire AtaiBeckley Inc., validating the sector and lifting sentiment across the space. </p> <p dir="ltr"></p> <p dir="ltr">AtaiBeckley shares are up 30.8% premarket, while Compass Pathways is up 7.4% and GH Research is up 18.9%.</p> <p dir="ltr">Under the deal, Lilly will acquire all outstanding AtaiBeckley shares for $6.75 per share in cash, plus up to $2.50 per share through a Contingent Value Right tied to development and regulatory milestones for AtaiBeckley&amp;#39;s lead programs, BPL-003 and VLS-01. </p> <p dir="ltr">The upfront cash consideration represents an aggregate equity value of http://www.streetinsider.com/General+News/Why+Psychedelic+stocks+are+surging+today/26776644.html Thu, 16 Jul 2026 07:17:49 -0400 ATAI GHRS http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Press+Releases/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html <p><strong>Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity</strong></p><p>NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- <em>Market News Updates</em> <em>News Commentary</em> - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients relied on traditional antidepressants that often took several weeks to start working—and didn't always help everyone. Today, drug developers are introducing a new wave of treatments designed to work faster, target different areas of the brain, and offer hope to people with treatment-resistant depression. Researchers are also exploring innovative approaches, including http://www.streetinsider.com/Globe+Newswire/Multi-Billion-Dollar+Battle+for+the+Future+of+Depression+Treatment+Has+Begun+Creating+a+Huge+Opportunity/26710487.html Tue, 30 Jun 2026 09:00:00 -0400 CMPS CMPS DFTX DFTX GHRS GHRS HELP HELP JNJ JNJ http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++GH+Research+PLC+++++++++++For%3A+Jun+26/26695003.html si-local-file:///var/storage/secattach/20260626/26695003.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++GH+Research+PLC+++++++++++For%3A+Jun+26/26695003.html Fri, 26 Jun 2026 07:30:00 -0400 GHRS O.50288575